All research
2026-07-17 PubMed

TRPM8 deficiency aggravates DSS-induced colitis by impairing CGRP release and IL-10 production

Transient Receptor Potential Melastatin 8 Plays a Key Role in Dextran Sulfate Sodium-Induced Murine Colitis via Regulating Extrinsic Sensory Neurons and Enteric Macrophage Secretory Activities.

Background

Inflammatory bowel disease (IBD), particularly colitis, involves complex immune responses and often lacks effective long-term treatments. Intestinal inflammation is regulated by various factors, including ion channels. Transient receptor potential melastatin 8 (TRPM8) is a cold-sensitive Ca2+-permeable ion channel known to influence intestinal inflammation. However, its specific role in modulating enteric macrophages and spinal afferent sensory neurons during dextran sulfate sodium (DSS)-induced colitis remained unclear, representing a critical gap in understanding disease progression and potential therapeutic targets.

Study Design

Researchers investigated TRPM8's role in dextran sulfate sodium (DSS)-induced colitis using TRPM8-deficient (KO) and wild-type (WT) mice. Colitis was induced with 2% DSS. They assessed inflammation via immunohistochemistry, reverse transcription-polymerase chain reaction (RT-qPCR), visceral sensing assessment, and flow cytometry. Further mechanistic studies used primary cultured dorsal root ganglion (DRG) neurons and bone marrow-derived macrophages (BMDMs) to evaluate lipopolysaccharide (LPS)-elicited responses and calcitonin gene-related peptide (CGRP) interactions.

Results

DSS-induced colitis was significantly aggravated in TRPM8-deficient (KO) mice compared to wild-type (WT) mice. In the colitis model, KO mice exhibited lower IL-10 mRNA levels than WT mice, while IL-6, IL-1β, and TNF-α levels remained unaffected. TRPM8 expression was upregulated in the distal colon and DRG following DSS administration. In the distal colon, TRPM8-immunoreactive cells colocalized with F4/80 (macrophages), and nerve fibers with substance P and calcitonin gene-related peptide (CGRP). In the DRG, TRPM8 neuron subtypes were labeled by neurofilament 200, substance P, CGRP, and tyrosine kinase receptor A.

In cultured DRG neurons, TRPM8 deficiency attenuated LPS-elicited CGRP release but did not affect substance P release. Furthermore, in BMDMs, TRPM8 deficiency significantly decreased LPS- and LPS/CGRP-elicited upregulation of IL-10 mRNA compared to WT animals, highlighting a critical role in macrophage secretory activities.

Key Findings

  • TRPM8 deficiency significantly aggravated DSS-induced colitis in mice.
  • TRPM8-deficient mice showed lower IL-10 mRNA levels in colitis, while IL-6, IL-1β, and TNF-α were unaffected.
  • TRPM8 expression was upregulated in the distal colon and DRG during DSS-induced colitis.
  • TRPM8 deficiency attenuated LPS-elicited CGRP release from cultured DRG neurons.
  • TRPM8 deficiency decreased LPS- and LPS/CGRP-elicited IL-10 mRNA upregulation in BMDMs.

Why It Matters

This study reveals a protective role for TRPM8 in colitis, suggesting that targeting this channel could offer a novel therapeutic strategy for inflammatory bowel diseases. By demonstrating that TRPM8 regulates both CGRP release from sensory neurons and IL-10 production in enteric macrophages, it provides a mechanistic basis for future interventions. Modulating TRPM8 activity could potentially enhance anti-inflammatory responses and improve outcomes in patients with colitis. While preclinical, these findings open avenues for developing compounds that activate TRPM8 or its downstream pathways to mitigate intestinal inflammation, moving towards a new class of anti-inflammatory agents.


trpm8 colitis inflammation il-10 cgrp macrophages
Source: pubmed:42464071 · Ingested 2026-07-17 · Digest: gemini-2.5-flash